NEW TREATMENT APPROACHES FOR VASCULOGENIC ERECTILE DYSFUNCTION
Introduction. In the initial stages of vasculogenic erectile dysfunction (ED), young men who are dissatisfied by administration of inhibitor 5-phosphodiesterase and/or intracavernous injections tend to deny surgical treatment. At the decompensated stage of ED penile prosthesis implantation presents the method of choice. However, currently there are new treatment approaches, the effectiveness of which is actively being investigated.Materials and methods. In article results of surgical treatment of 38 patients (25–48 years, mean age 34.3 ± 7.4 years) with vasculogenic ED are presented: 33 – venoocclusive ED, 5 – arterial insufficiency of the corpora cavernosa, 2 of them have hemodynamic and clinical signs of arteriovenous ED in subcompensation. The treatment included stenting or endovascular embolization with spirals.Results. Maximum follow-up was 4 years. Overall clinical effectiveness and subsequent sexual rehabilitation were assessed as sufficient based on the international index of erectile function before surgery was 10,5 ± 3,6 (9–13) and after surgery – 21,3 ± 4,2 (14–25) (p = 0,001).Conclusion. Application of these innovative technologies allows to perform a sexual rehabilitation of most patients with ED and to avoid phalloprosthesis implantation.